Article
Whole exome precision oncology targeting synthetic lethal vulnerabilities across the tumor transcriptome
2020-02-17
Abstract excerpt
Precision oncology has made significant advances in the last few years, mainly by targeting actionable mutations in cancer driver genes. However, the proportion of patients whose tumors can be targeted therapeutically remains limited. Recent studies have begun to explore the benefit of analyzing tumor transcriptomics data to guide patient treatment, raising the need for new approaches for systematically accomplish...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7c1fd5c4-706b-5e6f-bf6c-3db09ced49a8
- DOI
- 10.1101/2020.02.16.951699